IN THE UNITED STATES PATENT AND TRADEMARK OFFICE
`
`Patentee Acheampong et at
`
`Examiner Marcela
`
`Cordero Garcia
`
`PATENT
`
`PatentNo
`
`9248191
`
`Issue Date February
`
`2016
`
`For METHODS OF PROVIDING
`THERAPEUTIC EFFECTS USING
`CYCLOSPORIN COMPONENTS
`
`Group ArtUnit 1676
`
`Confirmation No 9616
`
`Customer No 51957
`
`REQUEST FOR CERTIFICATE OF CORRECTION
`
`Attn Certificate of Correction Branch
`
`Commissioner for Patents
`P.O Box 1450
`Alexandria VA 223 13-1450
`
`It is requested that Certificate of Correction be issued correcting printing errors appearing
`
`in the above-identified United States patent
`
`Pursuant to 1.20a the examiner
`
`of $100.00 or any additional
`
`fees or credit overpayment
`
`is authorized to charge the Certificate of Correction fee
`to Deposit Account No 010885
`
`Issuance of the Certificate of Correction would neither expand nor contract the scope of the
`
`claims as properly allowed and re-examination is not required
`
`Respectfully submitted
`
`Date February 16 2016
`
`By /Laura Wine
`Wine
`Laura
`Reg.No 68681
`
`FAMY CARE - EXHIBIT 1004-0001
`
`

`
`IN THE UNITED STATES PATENT AND TRADEMARK OFFICE
`
`Patentee Acheampong et at
`
`Examiner Marcela
`
`Cordero Garcia
`
`Group ArtUnit 1676
`
`Confirmation No 9616
`
`Customer No 51957
`
`PatentNo
`
`9248191
`
`Issue Date February
`
`2016
`
`For METHODS OF PROVIDING
`THERAPEUTIC EFFECTS USING
`CYCLOSPORIN COMPONENTS
`
`Attn Certificate of Correction Branch
`
`Commissioner for Patents
`P.O Box 1450
`Alexandria VA 223 13-1450
`
`We are transmitting herewith the attached
`
`for Certificate of Correction
`Request
`Certificate of Correction Form PTO-1050
`
`Please charge any additional
`
`fees or credit overpayment
`
`to Deposit Account No 010885
`
`Date February 16 2016
`
`Respectfully submitted
`
`/Laura Wine
`
`By Laura Wine
`Reg No.68681
`
`FAMY CARE - EXHIBIT 1004-0002
`
`

`
`PTO/SB/44 09-07
`0MB 0651 -0033
`Approved for use through 08/31/2013
`U.S Patent and Trademark Office U.S DEPARTMENT OF COMMERCE
`valid 0MB control number
`the Paperwork Reduction Act of 1995 no persons are required to respond to
`collection of information unless it displays
`Also Form PTO-1050
`
`Under
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`CERTIFICATE OF CORRECTION
`
`PATENT NO
`
`9248191
`
`DATED
`
`February
`
`2016
`
`INVENTORS
`
`Andrew Acheampong et al
`
`Page
`
`of
`
`It
`
`is certified that errors appear in the above-identified
`
`patent and that said Letters Patent
`
`is
`
`in Related U.S Application Data line
`
`which is
`
`therefor
`
`hereby corrected as shown below
`On the first page in field 63 in column
`delete and and insert
`On the Page
`
`in column
`
`under Other Publications
`
`line
`
`delete
`
`and
`
`insert
`
`therefor
`
`On the Page
`
`in column
`
`under Other Publications
`
`line 52 delete
`
`and
`
`insert
`
`therefor
`
`On the Page
`
`in column
`
`under Other Publications line 61 delete Muscosal
`
`and insert
`
`Mucosal
`
`therefor
`
`On the Page
`
`in column
`
`under Other Publications
`
`line 24 delete
`
`and
`
`insert
`
`therefor
`
`On the Page
`
`in column
`
`under Other Publications line 28 delete
`
`Polyocyethylene and insert
`
`Polyoxyethylene
`
`therefor
`
`On the Page
`
`in column
`
`under Other Publications line 29 delete
`
`PhysicoChemical
`
`and insert
`
`Physico-Chemical
`
`therefor
`
`On the Page
`
`in column
`
`under Other Publications
`
`line 39 delete
`
`and
`
`insert
`
`therefor
`
`On the Page
`
`in column
`
`under Other Publications
`
`line 13 delete
`
`and
`
`insert
`
`therefor
`
`On the Page
`
`in column
`
`under Other Publications
`
`line 35 delete
`
`and
`
`insert
`
`therefor
`
`On the Page
`
`in column
`
`insert
`
`Re-Examination
`
`under Other Publications line 48 after U.S
`
`FAMY CARE - EXHIBIT 1004-0003
`
`

`
`PTO/SB/44 09-07
`0MB 0651 -0033
`Approved for use through 08/31/2013
`U.S Patent and Trademark Office U.S DEPARTMENT OF COMMERCE
`valid 0MB control number
`the Paperwork Reduction Act of 1995 no persons are required to respond to
`collection of information unless it displays
`Also Form PTO-1050
`
`Under
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`CERTIFICATE OF CORRECTION
`
`PATENT NO
`
`9248191
`
`DATED
`
`February
`
`2016
`
`INVENTORS
`
`Andrew Acheampong et al
`
`Page
`
`of
`
`It
`
`is certified that errors appear in the above-identified
`
`patent and that said Letters Patent
`
`is
`
`hereby corrected as shown below
`under Other Publications line 10 delete Allegran
`On the Page
`
`in column
`
`and insert
`
`Allergan
`
`therefor
`
`On the Page
`
`in column
`
`under Other Publications line 43 delete Occular and
`
`insert
`
`Ocular
`
`therefor
`
`On the Page
`
`in column
`
`under Other Publications line 58 after Systane
`
`insert
`
`Products Systane
`
`On the Page
`
`in column
`
`under Other Publications line 59 delete http and
`
`insert
`
`http//
`
`therefor
`
`On the Page
`
`in column
`
`under Other Publications
`
`line 22 delete Waston and
`
`insert
`
`Watson
`
`therefor
`
`On the Page
`
`in column
`
`under Other Publications
`
`line 31 delete No and
`
`insert
`
`Nos
`
`therefor
`
`On the Page
`under Other Publications
`delete 5050213 and insert 505j2B
`under Other Publications line 48
`On the Page
`delete 5050213 and insert 505j2B
`delete 13/961.828 and insert
`
`in column
`
`in column
`
`line 33
`
`therefor
`
`therefor
`
`In column
`
`line
`
`13/961828
`
`therefor
`
`In column
`
`line 36 delete
`
`and insert
`
`In column
`
`In column
`
`In column
`
`line 37 delete
`and insert
`line 39 delete 2002 and insert
`line 53 delete al and insert
`
`therefor
`
`therefor
`
`2002
`
`therefor
`
`al
`
`therefor
`
`FAMY CARE - EXHIBIT 1004-0004
`
`

`
`PTO/SB/44 09-07
`0MB 0651 -0033
`Approved for use through 08/31/2013
`U.S Patent and Trademark Office U.S DEPARTMENT OF COMMERCE
`valid 0MB control number
`the Paperwork Reduction Act of 1995 no persons are required to respond to
`collection of information unless it displays
`Also Form PTO-1050
`
`Under
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`CERTIFICATE OF CORRECTION
`
`PATENT NO
`
`9248191
`
`DATED
`
`February
`
`2016
`
`INVENTORS
`
`Andrew Acheampong et al
`
`Page
`
`of
`
`It
`
`is certified that errors appear in the above-identified
`
`patent and that said Letters Patent
`
`is
`
`hereby corrected as shown below
`line 65 delete kerapoconjunctivitis
`
`In column
`
`and
`
`insert
`
`keratoconjunctivitis
`
`therefor
`
`In column
`
`In column
`
`In column
`
`line 12 delete clyclcosporin and insert
`line 52 delete were and insert
`line 23 After more insert
`
`are
`
`of
`
`cyclosporin
`
`therefor
`
`therefor
`
`In column
`
`line
`
`delete kerapoconjunctivitis
`
`and
`
`insert
`
`In column
`
`keratoconjunctivitis
`line 66 After with delete
`
`therefor
`
`In column
`
`line
`
`delete acetronitrile-based and insert
`
`acetonitrile-based
`
`the refo
`
`In column
`
`In column
`
`line 20 delete each and insert
`line 48 delete extant and insert
`
`such
`
`therefor
`
`extent
`
`therefor
`
`In column
`
`line 60 delete benefiting and insert
`In column 10 line 22 delete informing and insert
`
`benefitting
`
`therefor
`
`in forming
`
`therefor
`
`In column 10 line 35 delete amphorteric and insert
`
`amphoteric
`
`therefor
`
`In column 11 line
`
`delete methylhydroxyethlystarches and
`
`insert
`
`methylhydroxyethylstarches
`
`therefor
`
`In column 11 line 10 delete glucoaminoglycans and
`
`insert
`
`glycosaminoglycans
`
`therefor
`
`In column 11 line 28 delete 2-methacrylolyoxyethlysulfonic and
`
`insert
`
`2-methacryloyloxyethylsulfonic
`
`therefor
`
`FAMY CARE - EXHIBIT 1004-0005
`
`

`
`PTO/SB/44 09-07
`0MB 0651 -0033
`Approved for use through 08/31/2013
`U.S Patent and Trademark Office U.S DEPARTMENT OF COMMERCE
`valid 0MB control number
`the Paperwork Reduction Act of 1995 no persons are required to respond to
`collection of information unless it displays
`Also Form PTO-1050
`
`Under
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`CERTIFICATE OF CORRECTION
`
`PATENT NO
`
`9248191
`
`DATED
`
`February
`
`2016
`
`INVENTORS
`
`Andrew Acheampong et al
`
`Page
`
`of
`
`It
`
`is certified that errors appear in the above-identified
`
`patent and that said Letters Patent
`
`is
`
`hereby corrected as shown below
`In column 11 line 29 delete 2-methacryloyloxethylsulfonates and
`
`insert
`
`2-methacryloyloxyethylsulfonates
`
`therefor
`
`In column 11 line 30 delete 2-hydroxyproplysulfonic and
`
`insert
`
`2-hydroxypropylsulfonic
`
`therefor
`
`In column 11 line 45 delete crosslinked and insert
`
`cross-linked
`
`therefor
`
`In column 12 line
`
`In column 13 line
`
`delete polyvinyl and insert
`
`polyvinyl
`
`therefor
`
`delete Disoxide and insert
`
`Dioxide
`
`therefor
`
`In column 13 line 34 delete materiel and insert
`
`material
`
`therefor
`
`Pemulen
`In column 14 line 32 delete Premulen
`and insert
`In column 15 line 24 in Claim delete 005% and insert
`In column 15 line 61 in Claim 11 delete claim
`and insert
`
`0.05%
`
`claim
`
`therefor
`
`therefor
`
`the refo
`
`FAMY CARE - EXHIBIT 1004-0006
`
`

`
`Electronic Patent Application Fee Transmittal
`
`Application Number
`
`Filing Date
`
`14222478
`
`21-Mar-2014
`
`Title of Invention
`
`METHODS OF PROVIDING THERAPEUTIC EFFECTS USING CYCLOSPORIN
`COMPONENTS
`
`First Named Inventor/Applicant Name
`
`Andrew Acheampong
`
`Filer
`
`Laura Lee Wine/Maria
`
`Stein
`
`Attorney Docket Number
`
`17618C0N6C0N1 AP
`
`Filed as Large Entity
`
`Filing Fees for Utility under 35 USC 111
`
`Description
`
`Fee Code
`
`Quantity
`
`Amount
`
`Sub-Total
`
`in
`
`Basic Filing
`
`Pages
`
`Claims
`
`Miscellaneous-Filing
`
`Petition
`
`Patent-Appeals-and-Interference
`
`Post-Allowance-and-Post-Issuance
`
`Certificateof Correction
`
`1811
`
`100
`
`100
`
`FAMY CARE - EXHIBIT 1004-0007
`
`

`
`Description
`
`Fee Code
`
`Quantity
`
`Amount
`
`Sub-Total
`IJSD$
`
`in
`
`Extension-of-Time
`
`Miscellaneous
`
`TotaIinUSD$
`
`100
`
`FAMY CARE - EXHIBIT 1004-0008
`
`

`
`Electronic Acknowledgement Receipt
`
`EFSID
`
`Application Number
`
`24926019
`
`14222478
`
`International Application Number
`
`Confirmation Number
`
`9616
`
`Title of Invention
`
`METHODS OF PROVIDING THERAPEUTIC EFFECTS USING CYCLOSPORIN
`COMPONENTS
`
`First Named Inventor/Applicant Name
`
`Andrew Acheampong
`
`Customer Number
`
`51957
`
`Filer
`
`Laura Lee Wine/Maria
`
`Stein
`
`Filer Authorized By
`
`Laura Lee Wine
`
`Attorney Docket Number
`
`17618C0N6C0N1 AP
`
`Receipt Date
`
`Filing Date
`
`Time Stamp
`
`6-FEB-201
`
`21-MAR-2014
`
`164129
`
`Application Type
`
`Utility under 35 USC
`
`Payment information
`
`Submitted with Payment
`
`Payment Type
`
`Payment was successfully received in RAM
`
`RAM confirmation Number
`
`Deposit Account
`
`Authorized User
`
`yes
`
`Deposit Account
`
`$100
`
`3850
`
`010885
`
`WINE LAURA
`
`The Director of the USPTO is hereby authorized to charge indicated fees and credit any overpayment as follows
`
`Charge any Additional Fees required under 37 CFR 1.16 National application filing search and examination fees
`
`Charge any Additional Fees required under 37 CFR 1.17 Patent application and reexamination processing
`
`fees
`
`FAMY CARE - EXHIBIT 1004-0009
`
`

`
`Charge any Additional Fees required under 37 CFR 1.19 Document supply fees
`
`Charge any Additional Fees required under 37 CFR 1.20 Post
`
`Issuance fees
`
`Charge any Additional Fees required under 37 CFR 1.21 Miscellaneous fees and charges
`
`File Listing
`
`Document
`Number
`
`Warnings
`
`Information
`
`Warnings
`
`Information
`
`Document Description
`
`File Name
`
`File SizeBytesI
`Message Digest
`
`Multi
`
`Part I.zip
`
`Pages
`if appl
`
`Request
`
`for Certificate of Correction
`
`COCAllerganl 7618C0N6C0N1
`AP92481 91 .pdf
`
`Fee Worksheet SBO6
`
`fee-info.pdf
`
`164544
`
`808
`896d14531219586794181de91e1d8b525
`
`30499
`
`77d815d7d463771431
`
`b55d39b36969
`
`0015
`
`no
`
`no
`
`Total Files Size in bytes
`
`195043
`
`Receipt evidences receipt on the noted date by the USPTO of the indicated documents
`This Acknowledgement
`characterized by the applicant and including page counts where applicable It serves as evidence of receipt similarto
`Post Card as described in MPEP 503
`
`If
`
`New Applications Under 35 U.S.C 111
`filing date see 37 CFR
`new application is being filed and the application includes the necessary components for
`.53b-d and MPEP 506 Filing Receipt 37 CFR 1.54 will be issued in due course and the date shown on this
`Receipt will establish the filing date of the application
`Acknowledgement
`
`If
`
`National Stage of an International Application under 35 U.S.C 371
`timely submission to enter the national stage of an international application is compliant with the conditions of 35
`Form PCTIDOIEOI9O3
`U.S.C 371 and other applicable requirements
`indicating acceptance of the application as
`in due course
`national stage submission under 35 U.S.C 371 will be issued in addition to the Filing Receipt
`
`If
`
`New International Application Filed with the USPTO as Receiving Office
`new international application is being filed and the international application includes the necessary components for
`filing date see PCT Article 11 and MPEP 1810 Notification of the International Application Number
`an international
`and of the International Filing Date Form PCT/RO/105 will be issued in due course subject
`to prescriptions concerning
`national security and the date shown on this Acknowledgement
`Receipt will establish the international
`filing date of
`the application
`
`FAMY CARE - EXHIBIT 1004-0010
`
`

`
`UNITED STATES PATENT AND TRADEMARK OfficE
`
`OF COMMERCE
`UNITED STATES DEPARTMENT
`United States Patent and Trademark Office
`Address COMMISSIONER FOR PATENTS
`P.O Box 1450
`Alexarnfria Virginia 223 13-1450
`www.uspto.gov
`
`APPLICATION NO
`
`14/222478
`
`ISSUE DATE
`
`02/02/2016
`
`PATENT NO
`
`9248191
`
`ATTORNEY DOCKET NO
`17618C0N6C0N1 AP
`
`CONFIRMATION NO
`
`9616
`
`51957
`
`7590
`
`01/13/2016
`
`ALLERGAN INC
`2525 DUPONT DRIVE T2-7H
`IRVINE CA 92612-1599
`
`The projected patent number and issue date are specified above
`
`ISSUE NOTIFICATION
`
`Determination of Patent Term Adjustment under 35 U.S.C 154
`application filed on or after May 29 2000
`
`The Patent Term Adjustment is days Any patent to issue from the above-identified application will
`an indication of the adjustment on the front page
`
`include
`
`If Continued Prosecution Application CPA was filed in the above-identified
`determines Patent Term Adjustment is the filing date of the most recent CPA
`
`application the filing date that
`
`Applicant will be able to obtain more detailed information by accessing the Patent Application Information
`Retrieval PAIR WEB site http//pair.uspto.gov
`
`Any questions regarding the Patent Term Extension or Adjustment determination
`should be directed to the
`Office of Patent Legal Administration at 571-272-7702 Questions relating to issue and publication
`payments should be directed to the Application Assistance Unit AAU of the Office of Data Management
`0DM at 571-272-4200
`
`fee
`
`APPLICANTs Please see PAIR WEB site http//pair.iispto.gov for additional applicants
`
`Allergan Inc Irvine CA
`Andrew Acheampong Irvine CA
`Tang-Liii Las Vegas CA
`Diane
`Chang Newport Beach CA
`James
`Power San Clemente CA
`David
`
`The United States represents the largest most dynamic marketplace in the world and is an unparalleled location
`The USA offers tremendous
`for business investment innovation and commercialization of new technologies
`for those who invest and manufacture goods here Through SelectUSA our nation
`resources and advantages
`and facilitate business investment To learn more about why the USA is the best country in
`works to encourage
`the world to develop technology manufacture products and grow your business visit SelectUSA.gov
`
`1R103 Rev 10/09
`
`FAMY CARE - EXHIBIT 1004-0011
`
`

`
`UNITED STAmS PAmNT AND TRADEMARK OrncE
`
`NOTICE OF ALLOWANCE AND FEES DUE
`
`OF COMMERCE
`UNITED STATES DEPARTMENT
`United States Patent and Trademark Office
`Address COMMISSIONER FOR PATENTS
`P.O Box 1450
`Alexandria Virginia 223 13-1450
`
`www.uspto.gov
`
`51957
`
`7590
`
`12/18/2015
`
`ALLERGAN INC
`2525 DUPONT DRIVE T2-7H
`IRVINE CA 92612-1599
`
`EXAMINER
`
`CORDERO GARCIA MARCELA
`
`ART UNIT
`
`1676
`
`DATE MAILED 12/18/2015
`
`NUMBER
`
`APPLICATION NO
`
`FILING DATE
`
`14/222478
`
`03/21/2014
`
`ATTORNEY DOCKET NO
`17618C0N6C0N1 AP
`TITLE OF INVENTION METHODS OF PROVIDING THERAPEUTIC EFFECTS USING CYCLOSPORIN COMPONENTS
`
`FIRST NAMED INVENTOR
`
`Andrew Acheampong
`
`CONFIRMATION NO
`
`9616
`
`APPLN TYPE
`
`ENTITY STATUS
`
`ISSUE FEE DUE
`
`PUBLICATION
`
`FEE DUE
`
`PREV PAID ISSUE FEE
`
`TOTAL FEES DUE
`
`nonprovisional
`
`UNDISCOUNThD
`
`$960
`
`$0
`
`$0
`
`$960
`
`DATE DUE
`
`03/18/2016
`
`PATENT
`THE APPLICATION IDENTIFIED ABOVE HAS BEEN EXAMINED AND IS ALLOWED FOR ISSUANCE AS
`PROSECUTION ON THE MERITS IS CLOSED THIS NOTICE OF ALLOWANCE IS NOT
`GRANT OF PATENT RIGHTS
`THIS APPLICATION IS SUBJECT TO WITHDRAWAL
`FROM ISSUE AT THE INITIATIVE OF THE OFFICE OR UPON
`SEE 37 CFR 1.313 AND MPEP 1308
`PETITION BY THE APPLICANT
`THE ISSUE FEE AND PUBLICATION FEE IF REQUIRED MUST BE PAID WITHIN THREE MONTHS FROM THE
`MAILING DATE OF THIS NOTICE OR THIS APPLICATION SHALL BE REGARDED
`AS ABANDONED
`THIS
`STATUTORY PERIOD CANNOT BE EXTENDED
`SEE 35 U.S.C 151 THE ISSUE FEE DUE INDICATED ABOVE DOES
`CREDIT FOR ANY PREVIOUSLY PAID ISSUE FEE IN THIS APPLICATION
`IF AN ISSUE FEE HAS
`NOT REFLECT
`PREVIOUSLY BEEN PAID IN THIS APPLICATION AS SHOWN ABOVE THE RETURN OF PART
`OF THIS FORM
`REQUEST TO REAPPLY THE PREVIOUSLY PAID ISSUE FEE TOWARD THE ISSUE FEE NOW
`WILL BE CONSIDERED
`DUE
`
`HOW TO REPLY TO THIS NOTICE
`
`Review the ENTITY STATUS shown above If
`entity status still applies
`the ENTITY STATUS is the same as shown above pay the TOTAL FEES DUE shown above
`FEES TRANSMITTAL
`the ENTITY STATUS is changed from that shown above on PART
`Change in Entity Staths from status indicated above
`
`If
`
`If
`
`the ENTITY STATUS is shown as SMALL or MICRO verify whether entitlement to that
`
`complete section immber
`
`titled
`
`For purposes of this notice small entity fees are 1/2 the amoirnt of irndiscoirnted fees and micro entity fees are 1/2 the amoirnt of small entity
`fees
`
`II PART
`FEES TRANSMITTAL
`or its eqthvalent miist be completed and rethrned to the United States Patent and Trademark Office
`section 4b
`USPTO with your ISSUE FEE and PUBLICATION FEE if required If you are charging the fees to your deposit account
`Fees Transmittal should be completed and an extra copy of the form should be submitted If an equivalent of Part
`of Part
`is filed
`previously paid issue fee must be clearly made and delays in processing may occur due to the difficulty in recognizing
`to reapply
`request
`the paper as an equivalent of Part
`
`regarding this application must give the application number Please direct all communications
`III All communications
`Mail Stop ISSUE FEE unless advised to the contrary
`
`prior to issuance to
`
`IMPORTANT REMINDER Utility
`filed on or after Dec 12 1980 may require payment of
`issuing on applications
`patents
`is patentees responsibility to ensure timely payment of maintenance fees when due
`maintenance fees It
`
`PTOL-85 Rev 02/11
`
`Page
`
`of
`
`FAMY CARE - EXHIBIT 1004-0012
`
`

`
`PART
`
`FEES TRANSMITTAL
`
`Complete and send this form together with applicable fees to j\jj Mail Stop ISSUE FEE
`Commissioner
`for Patents
`P.O Box 1450
`Alexandria Virginia 22313-1450
`or Fax 571-273-2885
`
`FEE if
`transmitting the ISSUE FEE and PUBLICATION
`INSTRUCTIONS
`form should be used for
`including the Patent advance orders and notification of maintenance
`appropriate All
`further correspondence
`new correspondence
`indicated
`unless corrected
`below or directed otherwise in Block
`by
`specifying
`maintenance
`fee notifications
`
`This
`
`should be completed where
`required Blocks
`through
`address as
`fees will be mailed to the current correspondence
`separate FEE ADDRESS for
`address and/or
`indicating
`
`CURRENT CORRESPONDENCE
`
`ADDRESS Note Use Block
`
`for any change
`
`of address
`
`51957
`
`7590
`
`12/18/2015
`
`ALLEROAN INC
`2525 DUPONT DRIVE T2-7H
`IRVINE CA 92612-1599
`
`Note
`certificate of mailing can only be used for domestic mailings of the
`Fees Transmittal This certificate cannot be used for any other accompanying
`papers Each additional paper such as an assignment
`or formal drawing must
`have its own certificate of mailing or transmission
`
`Certificate of Mailing or Transmission
`this Fees Transmittal
`is being deposited with the United
`hereby certify that
`States Postal Service with sufficient postage for first class mail
`in an envelope
`to the Mail Stop ISSUE FEE address above
`addressed
`or being
`facsimile
`transmitted to the USPTO 571 273-2885 on the date indicated
`below
`
`Depositors
`
`name
`
`Signature
`
`Date
`
`CONFIRMATION NO
`
`9616
`
`DATE DUE
`
`03/18/2016
`
`APPLICATION NO
`
`14/222478
`
`FILING DATE
`
`03/21/2014
`
`ATTORNEY DOCKET NO
`17618C0N6C0N1 AP
`TITLE OF INVENTION METHODS OF PROVIDING THERAPEUTIC EFFECTS USING CYCLOSPORIN COMPONENTS
`
`FIRST NAMED INVENTOR
`
`Andrew Acheampong
`
`APPLN TYPE
`
`ENTITY STATUS
`
`ISSUE FEE DUE
`
`PUBLICATION
`
`FEE DUE
`
`PREV PAID ISSUE FEE
`
`TOTAL FEES DUE
`
`nonprovisional
`
`UNDISCOUNTED
`
`$960
`
`$0
`
`$0
`
`$960
`
`EXAMINER
`
`ART UNIT
`
`CLASS-SUBCLASS
`
`CORDERO GARCIA MARCELA
`
`1676
`
`14-020500
`
`address or indication of Fee Address 37
`
`For printing on the patent
`
`front page list
`
`patent attorneys
`
`Change of correspondence
`CFR 1.363
`The names of up to
`registered
`or agents OR alternatively
`address or Change of Correspondence
`Change of correspondence
`form PTO/SB/122 attached
`Address
`The name of
`single firm having as member
`Fee Address indication or Fee Address Indication form
`registered attorney or agent and the names of up to
`registered patent attorneys or agents If no name is
`Rev 03-02 or more recent attached Use of Customer
`PTO/SB/47
`listed no name will be printed
`Number
`is required
`JkSSIjNLL NAME AND RESIDENCE DATA TO BE PRINTED UN Nh PATENT print or type
`PLEASE NOTE Unless an assignee is identified below no assignee data will appear on the patent
`If an assignee is identified below the document
`recordation as set forth in 37 CFR 3.11 Completion of this form is NOT
`for filing an assignment
`NAME OF ASSIGNEE
`RESIDENCE CITY and STATE OR COUNTRY
`
`substitute
`
`has been filed for
`
`Please check the appropriate assignee category or categories will not be printed on the patent
`
`Individual
`
`Corporation or other private group entity
`
`Government
`
`4a The following fees are submitted
`
`Issue Fee
`Publication Fee No small entity discount permitted
`Advance Order
`
`of Copies
`
`4b Payment of Fees Please first
`check is enclosed
`
`reapply any previously paid issue fee shown above
`
`Payment by credit card Form PTO-2038
`The director is hereby authorized to charge the required fees any deficiency or credits any
`enclose an extra copy of this form
`to Deposit Account Number
`overpayment
`
`is attached
`
`Change in Entity Status from status indicated
`above
`Applicant certifying micro entity status See 37 CFR 1.29
`
`Applicant asserting small entity status See 37 CFR 1.27
`
`this box will be taken
`
`NOTE Absent
`valid certification of Micro Entity Status see forms PTO/SB/1SA
`and 1SB issue
`fee payment in the micro entity amount will not be accepted at the risk of application abandonment
`NOTE If
`the application was previously under micro entity status checking
`to be
`notification of loss of entitlement to micro entity status
`NOTE Checking
`this box will be taken to be
`entity status as applicable
`NOTE This form must be signed in accordance with 37 CFR 1.31 and 1.33 See 37 CFR 1.4 for signature requirements and certifications
`
`Applicant changing to regular undiscounted
`
`fee status
`
`notification of loss of entitlement to small or micro
`
`Authorized Signature
`
`Typed or printed name
`
`Date
`
`Registration No
`
`Page
`
`of
`
`PTOL-85 Part
`
`10-13 Approved for use through 10/31/2013
`
`0MB 0651-0033
`
`U.S Patent and Trademark Office U.S DEPARTMENT OF
`
`FAMY CARE - EXHIBIT 1004-0013
`
`

`
`UNITED STAms PAmNT AND TRADEMARK OfficE
`
`OF COMMERCE
`UNITED STATES DEPARTMENT
`United States Patent and Trademark Office
`Address COMMISSIONER FOR PATENTS
`P.O Box 1450
`AIexmdria Virghü 22313-1450
`www.uspto.gov
`
`APPLICATION NO
`
`FILING DATE
`
`14/222478
`
`03/21/2014
`
`FIRST NAMED INVENTOR
`
`Andrew Acheampong
`
`ATTORNEY DOCKET NO
`17618C0N6C0N1 AP
`
`CONFIRMATION NO
`
`9616
`
`51957
`
`7590
`
`12/18/2015
`
`ALLERGAN INC
`2525 DUPONT DRIVE T2-7H
`IRVINE CA 92612-1599
`
`EXAMINER
`
`CORDERO GARCIA MARCELA
`
`ART UNIT
`
`1676
`
`DATE MAILED 12/18/2015
`
`NUMBER
`
`Determination of Patent Term Adjustment under 35 U.S.C 154
`Applications filed on or after May 29 2000
`
`that
`
`Patent Term Adjustment PTA calculation with the Notice of Allowance
`The Office has discontinued providing
`Section 1h2 of
`the AlA Technical Corrections Act amended 35 U.S.C 154b3Bi
`to eliminate the
`term adjustment determination with the notice of allowance
`See
`the Office provide
`requirement
`patent
`Revisions to Patent Term Adjustment 78 Fed Reg 19416 19417 Apr
`2013 Therefore the Office is no longer
`term adjustment determination with the notice of allowance
`The Office will continue to
`providing an initial patent
`term adjustment determination with the Issue Notification Letter
`is mailed to applicant
`that
`provide
`patent
`approximately three weeks prior to the issue date of the patent and will
`include the patent term adjustment on the
`patent Any request for reconsideration of the patent
`term adjustment determination or reinstatement of patent term
`adjustment should follow the process outlined in 37 CFR 1.705
`
`Any questions regarding the Patent Term Extension or Adjustment determination should be directed to the Office of
`Patent Legal Administration at 571-272-7702 Questions relating to issue and publication fee payments should be
`directed to the Customer Service Center of the Office of Patent Publication at 1-888-786-0101 or 571-272-4200
`
`PTOL-85 Rev 02/11
`
`Page
`
`of
`
`FAMY CARE - EXHIBIT 1004-0014
`
`

`
`0MB Clearance and PRA Burden Statement
`
`for PTOL-85 Part
`
`The Paperwork Reduction Act PRA of 1995 requires Federal agencies to obtain Office of Management
`and
`Budget approval before requesting most types of information from the public When 0MB approves an agency
`information from the public 0MB
`valid 0MB Control Number and expiration
`to collect
`request
`provides
`the information and ii
`date for the agency to display on the instrument that will be used to collect
`requires the
`the 0MB Control Numbers legal significance
`CFR
`agency to inform the public about
`in accordance with
`1320.5b
`
`is required by 37 CFR 1.311 The information is required to obtain
`The information collected by PTOL-85 Part
`benefit by the public which is to file and by the USPTO to process an application Confidentiality is
`or retain
`governed by 35 U.S.C 122 and 37 CFR 1.14 This collection is estimated to take 12 minutes to complete
`application form to the USPTO Time will vary
`including gathering preparing and submitting the completed
`depending upon the individual case Any comments
`on the amount of
`time you require to complete this form
`to the Chief Information Officer U.S Patent and
`this burden should be sent
`and/or suggestions
`for reducing
`Trademark Office U.S Department of Commerce P.O Box 1450 Alexandria Virginia 22313-1450 DO NOT
`SEND FEES OR COMPLETED FORMS TO THIS ADDRESS SEND TO Commissioner for Patents P.O Box
`1450 Alexandria Virginia 22313-1450 Under
`the Paperwork Reduction Act of 1995 no persons are required to
`valid 0MB control number
`collection of information unless it displays
`respond to
`
`Privacy Act Statement
`
`The Privacy Act of 1974 P.L 93-579 requires that you be given certain information in connection with your
`form related
`submission of
`the attached
`to the
`patent application or patent Accordingly
`to
`pursuant
`requirements of the Act please be advised that
`the general authority for the collection of this information is
`35 U.S.C 2b2
`furnishing of the information solicited is voluntary and
`the principal purpose for which
`the information is used by the U.S Patent and Trademark Office is to process and/or examine your submission
`furnish the requested information the U.S Patent and
`If you do not
`related to
`patent application or patent
`Trademark Office may not be able to process and/or examine your submission which may result in termination of
`proceedings or abandonment of the application or expiration of the patent
`
`to
`
`to the following routine uses
`The information provided by you in this form will be subject
`the Freedom of
`The information on this form will be treated confidentially to the extent allowed under
`U.S.C 552 and the Privacy Act
`U.S.C 552a Records from this system of records
`Information Act
`of Justice to determine whether disclosure of these records is required
`may be disclosed to the Department
`by the Freedom of Information Act
`record from this system of records may be disclosed as
`routine use in the course of presenting evidence
`in the course of
`court magistrate or administrative tribunal
`including disclosures
`to opposing counsel
`settlement negotiations
`routine use to Member of Congress submitting
`record in this system of records may be disclosed as
`to whom the record pertains when the individual has requested assistance
`involving an individual
`request
`from the Member with respect
`to the subject matter of the record
`record in this system of records may be disclosed as
`contractor of the Agency having
`routine use to
`need for the information in order to perform
`information shall be required to
`contract Recipients of
`to U.S.C 552am
`comply with the requirements of the Privacy Act of 1974 as amended pursuant
`record related to an International Application filed under
`the Patent Cooperation Treaty in this system of
`routine use to the International Bureau of the World Intellectual Property
`records may be disclosed as
`to the Patent Cooperation Treaty
`Organization pursuant
`federal agency for purposes
`routine use to another
`record in this system of records may be disclosed as
`to the Atomic Energy Act 42 U.S.C
`of National Security review 35 U.S.C 181 and for review pursuant
`18c
`record from this system of records may be disclosed as
`routine use to the Administrator General
`conducted by GSA as part of
`Services or his/her designee during an inspection of records
`that agencys
`responsibility to recommend improvements in records management practices and programs under authority
`shall be made in accordance with the GSA regulations
`of 44 U.S.C 2904 and 2906 Such disclosure
`i.e GSA or Commerce directive
`governing inspection of records for this purpose and any other
`relevant
`Such disclosure shall not be used to make determinations about
`individuals
`record from this system of records may be disclosed as
`routine use to the public after either publication
`to 35 U.S.C 122b or issuance of
`to 35 U.S.C 151 Further
`of the application pursuant
`patent pursuant
`to the limitations of 37 CFR 1.14 as
`record may be disclosed subject
`routine use to the public if
`the
`record was filed in an application which became abandoned or in which the proceedings were terminated
`and which application is referenced
`by either
`an application open to public
`inspection or an issued patent
`law
`record from this system of records may be disclosed as
`routine use to
`Federal State or local
`the USPTO becomes aware of
`violation or potential violation of law or regulation
`enforcement agency
`if
`
`published application
`
`FAMY CARE - EXHIBIT 1004-0015
`
`

`
`Applicant-Initiated Interview Summary
`
`Application No
`
`Applicants
`
`14/222478
`
`Examiner
`
`MARCELA
`GARCIA
`
`ACHEAMPONG ET AL
`
`Art Unit
`
`CORDERO
`
`1676
`
`All participants applicant applicants representative PTO personnel
`
`MARCELA
`
`CORDERO GARCIA
`
`LAURA L.WINE
`
`Date of
`
`Interview 11 December 2015
`
`Type
`
`Telephonic
`Personal
`
`Video Conference
`given to
`
`applicant
`
`applicants representative
`
`Exhibit shown or demonstration conducted
`If Yes brief description ______
`
`Yes
`
`No
`
`Issues Discussed ElOl E112 E102 E103 MOthers
`For each of the checked boxes above please describe below the issue and detailed description of the discussion
`
`Claims discussed All in general
`
`Identification of prior art discussed US 9101574
`
`Substance of
`
`Interview
`
`detailed description and indicate if agreement was reached Some topics may include identification or clarification of
`For each issue discussed provide
`portion thereof claim interpretation proposed amendments arguments of any applied references etc..
`reference or
`
`See Continuation Sheet
`
`recordation instructions The formal written reply to the last Office action must include the substance of the interview See MPEP
`Applicant
`reply to the last Office action has already been filed applicant
`the longer of one month or
`section 713.04 If
`non -extendable period of
`is given
`this interview summary form whichever
`the substance of the
`thirty days from this interview date or the mailing date of
`statement of
`is later to file
`interview
`
`complete and proper
`Examiner recordation instructions Examiners must summarize the substance of any interview of record
`the substance of an interview should include the items listed in MPEP 713.04 for complete and proper
`recordation including the identification of the
`thrust of each argument or issue discussed
`indication of any other pertinent matters discussed regarding patentability
`and the
`general
`general
`results or outcome of the interview to include an indication as to whether or not agreement was reached on the issues raised
`
`recordation of
`
`general
`
`Attachment
`
`J.S Patent and Trademark Office
`PTOL-413 Rev 8/11/2010
`
`Interview Summary
`
`Paper No 20151214
`
`FAMY CARE - EXHIBIT 1004-0016
`
`

`
`Summary of Record of Interview Requirements
`
`Manual of Patent Examining Procedure MPEP Section 713.04 Substance of
`video conference
`as to the substance of any face-to-face
`complete written statement
`application whether or not an agreement with the examiner was reached at the interview
`
`Interview Must be Made of Record
`interview with regard to an application must be made of record in the
`
`or telephone
`
`Title 37 Code of Federal Regulations CFR 1.133 Interviews
`Paragraph
`
`the interview as
`complete written statement of the reasons present